SPCE - Hot Stocks: MRK buys XLRN; KMX profit miss; KSS downgrade; SPCE cleared to fly
An $11.5B merger deal highlighted Thursday's premarket trading. Confirming recent reports, Merck (NYSE:MRK) signed a deal to acquire Acceleron (NASDAQ:XLRN). In other news, CarMax (NYSE:KMX) lost ground before the bell after its bottom line failed to meet expectations. Kohl's (NYSE:KSS) also experienced selling pressure, pulled down by an analyst's downgrade. Looking at some of the big pre-market winners, OptimizeRx (NASDAQ:OPRX) jumped on inclusion in the S&P SmallCap 600 index and on a change in its C-Suite. Elsewhere, Virgin Galactic (NYSE:SPCE) drew buying interest after it received a favorable regulatory ruling. Gainer Merck (MRK) has agreed to acquire Acceleron (XLRN) in a deal worth nearly $11.5B. The purchase price equates to $180 per share in cash. XLRN was little changed on the news in pre-market action, edging up by less than 1%. However, the stock had rallied over the past week or so on speculation of an impending deal. OptimizeRx (OPRX) gained
For further details see:
Hot Stocks: MRK buys XLRN; KMX profit miss; KSS downgrade; SPCE cleared to fly